98%
921
2 minutes
20
Diabetic retinopathy (DR) is one of the most common microvascular complications in diabetic patients, severely affecting their vision and quality of life. However, the precise molecular mechanisms underlying DR remain unclear. In recent years, mitochondrial ribosomal protein S10 (Mrps10) gene has gained attention due to its high expression, which may be associated with various metabolic disorders. This study aims to explore the expression profile of Mrps10 in diabetic retinopathy and its potential molecular mechanisms. To investigate the expression profile of Mrps10 in DR and explore its potential molecular mechanisms through integrated bioinformatics analysis of public transcriptomic data. We downloaded the diabetic retinopathy dataset GSE111465 from the gene expression omnibus database and used the "limma" package to identify differentially expressed genes. Functional enrichment analysis of differentially expressed genes was conducted through gene ontology analysis, Kyoto encyclopedia of genes and genomes pathway analysis, and metascape enrichment analysis. We also constructed gene modules using weighted gene co-expression network analysis and identified hub genes related to Dr Furthermore, the potential role of Mrps10 in DR was verified using protein-protein interaction networks and the comparative toxicogenomics database. Our study showed that Mrps10 was significantly overexpressed in the retinal tissues of diabetic retinopathy patients. Functional enrichment analysis revealed its association with mitochondrial dysfunction, oxidative stress, and other biological processes. Protein-protein interaction network analysis identified multiple key genes interacting with Mrps10, suggesting its regulatory role in the onset and progression of Dr Comparative toxicogenomics database analysis further supported the hypothesis that high Mrps10 expression is linked to Dr Mrps10 may promote the progression of diabetic retinopathy by regulating mitochondrial function and oxidative stress pathways, indicating its potential as a molecular target for Dr Future research should further investigate the biological functions of Mrps10 and its role in diabetic retinopathy to provide new insights for molecular-targeted therapies for Dr.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401390 | PMC |
http://dx.doi.org/10.1097/MD.0000000000044179 | DOI Listing |
JMIR Med Inform
September 2025
Global Health Economics Centre, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Background: Artificial intelligence (AI) algorithms offer an effective solution to alleviate the burden of diabetic retinopathy (DR) screening in public health settings. However, there are challenges in translating diagnostic performance and its application when deployed in real-world conditions.
Objective: This study aimed to assess the technical feasibility of integration and diagnostic performance of validated DR screening (DRS) AI algorithms in real-world outpatient public health settings.
Biochem Biophys Res Commun
September 2025
Department of Ophthalmology, Hebei Medical University, NO. 361 Zhongshan East Road, Changan District, Shijiazhuang City, Hebei Province, China; Department of Ophthalmology, Hebei General Hospital, NO. 348 Heping West Road, Xinhua District, Shijiazhuang City, Hebei Province, China. Electronic address
Diabetic retinopathy (DR) is among the most prevalent complications linked to advanced diabetes. Capillary Basement membrane (CBM) thickening is an early clinical manifestation in DR, and Laminin α 1 (LAMA1) is one of the main extracellular matrix components involved in CBM formation. Dapagliflozin (DAPA) has demonstrated efficacy in ameliorating DR.
View Article and Find Full Text PDFRetina
September 2025
Harvard Retinal Imaging Lab, Massachusetts Eye and Ear, Boston, MA, USA.
Purpose: To investigate associations among expanded field swept-source optical coherence tomography angiography (SS-OCTA) biomarkers and the development of tractional retinal detachment (TRD) in patients with proliferative diabetic retinopathy (PDR).
Methods: Patients with PDR without TRD at baseline were imaged with SS-OCTA. Quantitative and qualitative OCTA metrics were independently evaluated by two trained graders.
Jpn J Ophthalmol
September 2025
Department of Ophthalmology, Osaka University Graduate School of Medicine, Room E7, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Abtract: PURPOSE: To evaluate the correlation between corneal backscatter and visual function in patients with Fuchs endothelial corneal dystrophy (FECD).
Study Design: Prospective case series.
Methods: This study included 53 eyes from 38 patients with FECD.
Graefes Arch Clin Exp Ophthalmol
September 2025
Department of Physics of Condensed Matter, Optics Area. Vision Research Group (CIVIUS), University of Seville, Avenida de la Reina Mercedes s/n (41012), Seville, Spain.
Purpose: To analyze the relationship between various visual function parameters (refractive status, visual acuity and contrast sensitivity) and macular pigment optical density (MPOD) values, as well as dietary intake of lutein and zeaxanthin in a pediatric population.
Methods: Thirty-six healthy White pediatric patients participated in this cross-sectional study conducted at the Optometry Clinic (Faculty of Pharmacy, Seville, Spain). MPOD values were measured using the MPSII (Macular Pigment Screener II).